EcoDrugPlus

Opioid Receptor, Mu 1

Ensembl ID : ENSOTSG00005004696
Gene Symbol: OPRM1
1 Cross references
207 Possible Orthologues:

Oxysterols Receptor Lxr-Alpha-Like

Ensembl ID : ENSOTSG00005019168
Gene Symbol: LOC112248987
3 Cross references
384 Possible Orthologues:

Oxysterols Receptor Lxr-Alpha-Like

Ensembl ID : ENSOTSG00005023506
Gene Symbol: LOC112232277
3 Cross references
384 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSOTSG00005000151
Gene Symbol: OXTR
3 Cross references
177 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSOTSG00005025703
Gene Symbol: OXTR
1 Cross references
177 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSOTSG00005024066
Gene Symbol: PTH1R
1 Cross references
190 Possible Orthologues:

Parathyroid Hormone/parathyroid Hormone-Related Peptide Receptor-Like

Ensembl ID : ENSOTSG00005045013
Gene Symbol: LOC112226782
3 Cross references
190 Possible Orthologues:

Permeability Factor 2-Like

Ensembl ID : ENSOTSG00005038285
Gene Symbol: LOC112234506
2 Cross references
178 Possible Orthologues:

Permeability Factor 2-Like

Ensembl ID : ENSOTSG00005026597
Gene Symbol: LOC112234506
2 Cross references
178 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSOTSG00005033592
Gene Symbol: PPARD
1 Cross references
345 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSOTSG00005031463
Gene Symbol: PPARD
3 Cross references
345 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSOTSG00005028118
Gene Symbol: PPARG
1 Cross references
389 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).